Birth Control News
-
Updated 1 hour, 19 minutes ago
Nintendo Co. fended off a second U.S. patent-infringement case this month against its Wii video-game system, adding to a trend of companies fighting royalty demands and winning.
-
Actavis Inc., the largest U.S. maker of generic drugs by market value, agreed to acquire Warner Chilcott Plc for about $5 billion excluding net debt in a deal to expand in women’s health and urology.
-
Teva Pharmaceutical Industries Ltd. resumes trading today in Tel Aviv at the biggest discount to New York in 2 1/2 years after the prospect of acquisitions among generic-drug makers fueled gains in its U.S.-traded stock.
-
Actavis Inc. stands to return 17 percent more to shareholders by acquiring birth-control drugmaker Warner Chilcott Plc than selling itself.
-
The U.S. government asked a federal appeals court to delay a trial judge’s ruling that would grant women of all ages over-the-counter access to the so-called morning after birth-control pill.
-
President Barack Obama gathered women and their families at the White House two days before Mother’s Day to promote benefits in his signature health care law such as free mammograms and birth control.
-
Actavis Inc., the largest U.S. maker of generic drugs by market value, said it’s in “early stage discussions” to buy Warner Chilcott Plc, the drugmaker that unsuccessfully pursued a sale last year.
-
A federal judge rejected as “frivolous” a government request to delay the effect of his order giving girls including those 16 and younger access to the so-called morning after-pill without a prescription.
-
A federal judge criticized the government’s request to delay a ruling allowing girls over-the- counter access to the “morning after” pill while the administration appeals the order.
-
Actavis Inc., the generic drugmaker whose merger negotiations with Valeant Pharmaceuticals International Inc. stalled over price, may deserve the industry’s second-best valuation ever in a deal.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page